Aroa Biosurgery Limited (AROAF)
OTCMKTS · Delayed Price · Currency is USD
0.3500
0.00 (0.00%)
Jul 29, 2025, 4:00 PM EDT
Chimerix Market Cap
Aroa Biosurgery has a market cap or net worth of $142.50 million as of August 1, 2025. Its market cap has increased by 4.01% in one year.
Market Cap
142.50M
Enterprise Value
133.28M
Revenue
48.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.35
Market Cap Chart
Since July 24, 2020, Aroa Biosurgery's market cap has decreased from 287.41M to 142.50M, a decrease of -50.42%. That is a compound annual growth rate of -13.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 139.78M | -14.95% |
| Dec 31, 2024 | 164.35M | -15.42% |
| Dec 29, 2023 | 194.31M | -22.80% |
| Dec 30, 2022 | 251.70M | -0.85% |
| Dec 31, 2021 | 253.87M | -4.85% |
| Dec 31, 2020 | 266.81M | -7.17% |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.76B |
| Veradigm | 794.80M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 546.09M |
| Glass House Brands | 409.73M |
| Nika Pharmaceuticals | 366.89M |
| Northwest Biotherapeutics | 361.28M |
| CytoDyn | 357.98M |